James A. Root
AstraZeneca (Sweden) · 15 works · 603 citations · h-index 9
Top works
- In vitroandin vivocharacterization of PF‐04418948, a novel, potent and selective prostaglandin EP2receptor antagonist
- Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
- Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects
- Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition
- Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence
- Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs
- Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5- d ]azepines as Potent 5-Hydroxytryptamine 2C (5-HT 2C ) Receptor Agonists with Exquisite Functional Selectivity over 5-HT 2A and 5-HT 2B Receptors
- Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease
- Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro
- Target engagement confirmed in man with a dipeptidyl peptidase 1 inhibitor
- Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation
- Safety of medicine and the use of animals in research
- Opioid receptor characterisation of neuronally stimulated isolated human vas deferens
- Linking Increased Airway Hydration, Ciliary Beating
- COPD lungs show an attached stratified mucus layer resembling the protective colonic mucus